Centrilobular zonal necrosis as a hallmark of a distinctive subtype of autoimmune hepatitis

Eur J Gastroenterol Hepatol. 2016 Apr;28(4):391-7. doi: 10.1097/MEG.0000000000000545.

Abstract

Background and aim: Centrilobular zonal necrosis (CZN) is a known histological variant of autoimmune hepatitis (AIH). However, the significance of CZN is yet to be fully elucidated. This study aimed to determine whether CZN is a hallmark of a distinctive subtype of AIH.

Methods: Histological changes in the centrilobular zones of liver biopsies from 113 AIH patients were assessed by a single pathologist and classified into three categories: typical zonal necrosis defined as CZN (15 patients); other necroinflammatory change (NIC; 24 patients); and absence of necrosis (non-NIC; 74 patients). The clinicopathological features and immunogenetic background of CZN patients were then assessed.

Results: The clinicopathological features of AIH with CZN were distinct from other types of AIH, including a higher frequency of acute onset, lower frequency of antinuclear antibodies, lower antinuclear antibody titers, lower serum immunoglobulin G levels, lower grade interface hepatitis, less prominent lymphoplasmacytic infiltration, and lower AIH score. Increased and decreased frequencies of HLA-DR9 and HLA-DR4, respectively, were identified as immunogenetic features of AIH with CZN. Conversely, the clinicopathological characteristics of AIH with NIC were similar to those of non-NIC AIH, including the majority of the AIH patients. The therapeutic outcomes of AIH with CZN were excellent when precise diagnoses were made without delay.

Conclusion: The clinicopathological features and immunogenetic background of AIH with CZN differed from AIH without CZN. CZN may be a hallmark of a distinct subtype of AIH.

Publication types

  • Comparative Study
  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Autoantibodies / blood
  • Biomarkers / blood
  • Biopsy
  • Case-Control Studies
  • Female
  • HLA-DR Antigens / immunology
  • Hepatitis, Autoimmune / classification
  • Hepatitis, Autoimmune / drug therapy
  • Hepatitis, Autoimmune / immunology
  • Hepatitis, Autoimmune / pathology*
  • Humans
  • Immunoglobulin M / blood
  • Immunosuppressive Agents / therapeutic use
  • Japan
  • Liver / drug effects
  • Liver / immunology
  • Liver / pathology*
  • Liver Cirrhosis / immunology
  • Liver Cirrhosis / pathology
  • Male
  • Middle Aged
  • Necrosis
  • Predictive Value of Tests
  • Treatment Outcome

Substances

  • Autoantibodies
  • Biomarkers
  • HLA-DR Antigens
  • Immunoglobulin M
  • Immunosuppressive Agents